The medicated feed additives market has seen considerable growth due to a variety of factors.
•There has been a consistent increase in the market size of medicated feed additives in recent years. The market, valued at $13.68 billion in 2024, is projected to reach $14.33 billion in 2025, implying a compound annual growth rate (CAGR) of 4.8%.
The notable growth witnessed in the historical phase can be linked to factors like widespread animal diseases, improved feed efficiency, government legislation for feed security, the internationalization of the feed additives industry, and their preventive role in disease control strategies.
The medicated feed additives market is expected to maintain its strong growth trajectory in upcoming years.
• In the years to come, the market for medicated feed additives is projected to witness significant growth. The market is set to expand to "$17.69 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%.
The expansion within this timeframe can be accredited to an increase in aquaculture production, attention towards maintaining gut health and digestive functionality, as well as ethical and sustainable farming methods, research into antimicrobial peptides, and collective global efforts towards disease eradication. Some of the primary trends for the forecast period involve considerable investments in R&D, product innovations, and advancements in the animal feed sector.
The upward trend in poultry product consumption is anticipated to fuel the expansion of the medicated feed additives market. Poultry products refer to a poultry carcass or any product partially or completely made from a poultry carcass, even those with a minimal percentage of poultry ingredients. Medicated feed additives, used for the prevention and treatment of coccidiosis, a parasitic intestinal tract disease in animals caused by coccidian protozoa, and necrotic enteritis, a poultry enteric disease, will see an increase in demand to maintain poultry health due to this rise in consumption. For instance, in August 2022, the United States Department of Agriculture, a federal executive department in the US, reported global poultry imports in 2021 amounted to 14.2 million metric tons. This number is predicted to see a 24% increase, reaching 17.5 million metric tons by 2031. Thus, the escalating consumption of poultry products is a key driver for the growth of the medicated feed additives market.
The medicated feed additives market covered in this report is segmented –
1) By Type: Antibiotics, Vitamins, Antioxidants, Amino Acids, Prebiotics, Probiotics, Enzymes, Other Types
2) By Animal Type: Ruminants, Swine, Poultry, Aquaculture, Other Animal Types
3) By Mixture Type: Supplements, Concentrates, Premixes, Base Mixes
Subsegments:
1) By Antibiotics: Tetracyclines, Macrolides, Penicillins, Sulfonamides
2) By Vitamins: Vitamin A, Vitamin D, Vitamin E, Vitamin B Complex
3) By Antioxidants: Synthetic Antioxidants, Natural Antioxidants
4) By Amino Acids: Essential Amino Acids, Non-Essential Amino Acids
5) By Prebiotics: Fructooligosaccharides (FOS), Mannanoligosaccharides (MOS)
6) By Probiotics: Bacterial Probiotics, Yeast Probiotics
7) By Enzymes: Digestive Enzymes, Metabolic Enzymes
8) By Other Types: Phytogenics, Organic Acids
The trend of product innovation is increasingly becoming crucial in the medicated feed additives market. Major players in the market are focusing their energies on developing innovative products, which include the creation of new active substances, the implementation of different delivery methods, combined products, and precision medicine. For example, Evonik Industries, a chemical manufacturing firm based in Germany, launched an improved version of its product Biolys for animal feed in June 2023. This new formulation contains a higher level of L-lysine, a vital amino acid necessary for the ideal nutrition of animals, particularly pigs and poultry. The updated Biolys offers a more effective L-lysine source, promoting better growth and feed efficiency in livestock. This progress in Biolys technology by Evonik signifies its emphasis on sustainability, effectiveness, and increased nutritional value in animal feed.
Major companies operating in the medicated feed additives market include:
• Archer-Daniels-Midland Company
• Cargill Incorporated
• CHS Inc.
• Zoetis Services LLC
• Purina Animal Nutrition LLC
• China National Bluestar (Group) Co. Ltd.
• Alltech
• Zagro Corporation
• Hi-Pro Feeds
• Biostadt Limited
• BASF SE
• Evonik Industries AG
• Novozymes A/S
• Nutreco NV
• Phibro Animal Health Corporation
• Chr. Hansen A/S
• Red Nucleus LLC
• MITSUI & Co. Ltd.
• FEED ONE Co. Ltd.
• NOSAN CORPORATION
• Kemin Industries Inc.
• Provimi Holding BV
• Lallemand Inc.
• Novus International Inc.
• DSM Nutritional Products AG
• DuPont de Nemours Inc.
• Trouw Nutrition International B.V.
• Koninklijke DSM N.V.
• Solvay SA
• Ajinomoto Co. Inc.
Asia-Pacific was the largest region in the medicated feed additives market in 2024. The regions covered in the medicated feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa